Publications by authors named "Debbie Becker"

Claim this Profile
C
Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling study.
Ben Parker, Tom Ward, Olivia Hayward, Ian Jacob, Erin Arthurs, Debbie Becker

PLoS One· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization.
Michele Kohli, Michael Maschio, Debbie Becker, Milton C Weinstein

Vaccine· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors.
Debbie L Becker, Ayman Chit, Carlos A DiazGranados, Michael Maschio, Eddy Yau

Hum Vaccin Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
Ayman Chit, Debbie L Becker, Carlos A DiazGranados, Michael Maschio, Eddy Yau

Lancet Infect Dis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals in Mexico.
Iris Contreras-Hernandez, Debbie Becker, Jeremy Chancellor, Felicitas Kühne, Joaquin Mould-Quevedo

Value Health· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of linezolid utilization in selected canadian provinces.
Sandra Walker, Linda Dresser, Debbie Becker, Alissa Scalera

Can J Infect Dis Med Microbiol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a health education intervention in overactive bladder patients.
Sender Herschorn, Debbie Becker, Elizabeth Miller, Melissa Thompson, Lindy Forte

Can J Urol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The costs and consequences of methicillin-resistant Staphylococcus aureus infection treatments in Canada.
Andrew J Rosner, Debbie L Becker, Angelina H Wong, Elizabeth Miller, John M Conly

Can J Infect Dis Med Microbiol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective analysis of practice patterns in the treatment of methicillin-resistant Staphylococcus aureus skin and soft tissue infections at three Canadian tertiary care centres.
John M Conly, H Grant Stiver, Karl A Weiss, Debbie L Becker, Andrew J Rosner

Can J Infect Dis· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia.
Michael F Drummond, Debbie L Becker, Margaret Hux, Jeremy V M Chancellor, Isabelle Duprat-Lomon

Chest· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis